Skip to main content
Caplight Logo









Vilya

Vilya

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://vilyatx.com/

Last Round

Series A

Jun 4, 2024

Est. Valuation

$144M

Total Funding Raised

$142M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Vilya is a biotechnology company that develops a computational platform for creating a novel class of medicines that precisely target disease biology through the design of macrocycles.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

macrocycledrug discoverycomputational designAI-enabled drug discoverymacrocyclic peptidesde novo designprotein designundruggable targetsAI biotechintracellular targetscell permeabilityin silico drug designtherapeutic developmentdrug modalitygenerative biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vilya Comparables

Compare Vilya with similar companies based on industry and business-model similarity.

Vilya comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orbis Medicines
86%
Unnatural Products
86%
Curve Therapeutics
82%

Vilya Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 4, 2024
Series AAug 29, 2022

Key People

Founding team and executive leadership

Patrick Salveson

Co-founder & Chief Technology Officer

Founding Team

Vilya Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 84% MoM.

  • Jun 4, 2024

    $71M round led by NVentures and ARCH Venture Partners.

Vilya Filings

Explore SEC and related filing metadata, where available.

Vilya filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vilya's valuation, stock price, and market status.

Is Vilya a public or private company?

Vilya is a private company.

What is the current stock price of Vilya?

Vilya is a private company with no public stock price. No recent secondary market data is available.

How much is Vilya worth (valuation)?

Valuation information for Vilya is not publicly available.

Can I buy Vilya stock?

Vilya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vilya's last funding round?

Vilya's most recent funding round was Series A on June 4, 2024.

Who are the main investors in Vilya?

Key investors in Vilya include ARCH Venture Partners, NVentures.

Will Vilya IPO soon?

No public IPO plans have been announced for Vilya.

How can I track Vilya secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vilya's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range43
Year Founded2022
Last FundingJun 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?